300 related articles for article (PubMed ID: 28384474)
1. Polyglutamine-Expanded Huntingtin Exacerbates Age-Related Disruption of Nuclear Integrity and Nucleocytoplasmic Transport.
Gasset-Rosa F; Chillon-Marinas C; Goginashvili A; Atwal RS; Artates JW; Tabet R; Wheeler VC; Bang AG; Cleveland DW; Lagier-Tourenne C
Neuron; 2017 Apr; 94(1):48-57.e4. PubMed ID: 28384474
[TBL] [Abstract][Full Text] [Related]
2. Role of the ribosomal quality control machinery in nucleocytoplasmic translocation of polyQ-expanded huntingtin exon-1.
Zheng J; Yang J; Choe YJ; Hao X; Cao X; Zhao Q; Zhang Y; Franssens V; Hartl FU; Nyström T; Winderickx J; Liu B
Biochem Biophys Res Commun; 2017 Nov; 493(1):708-717. PubMed ID: 28864412
[TBL] [Abstract][Full Text] [Related]
3. Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease.
Truant R; Atwal RS; Burtnik A
Prog Neurobiol; 2007 Nov; 83(4):211-27. PubMed ID: 17240517
[TBL] [Abstract][Full Text] [Related]
4. Focal distortion of the nuclear envelope by huntingtin aggregates revealed by lamin immunostaining.
Chapple JP; Bros-Facer V; Butler R; Gallo JM
Neurosci Lett; 2008 Dec; 447(2-3):172-4. PubMed ID: 18840504
[TBL] [Abstract][Full Text] [Related]
5. A gene delivery system containing nuclear localization signal: Increased nucleus import and transfection efficiency with the assistance of RanGAP1.
Chen K; Guo L; Zhang J; Chen Q; Wang K; Li C; Li W; Qiao M; Zhao X; Hu H; Chen D
Acta Biomater; 2017 Jan; 48():215-226. PubMed ID: 27816620
[TBL] [Abstract][Full Text] [Related]
6. Are there multiple pathways in the pathogenesis of Huntington's disease?
Aronin N; Kim M; Laforet G; DiFiglia M
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):995-1003. PubMed ID: 10434298
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
Lee WC; Yoshihara M; Littleton JT
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
[TBL] [Abstract][Full Text] [Related]
8. Huntington's disease: From molecular basis to therapeutic advances.
Krobitsch S; Kazantsev AG
Int J Biochem Cell Biol; 2011 Jan; 43(1):20-4. PubMed ID: 21056115
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the nuclear matrix protein NAKAP with HypA and huntingtin: implications for nuclear toxicity in Huntington's disease pathogenesis.
Sayer JA; Manczak M; Akileswaran L; Reddy PH; Coghlan VM
Neuromolecular Med; 2005; 7(4):297-310. PubMed ID: 16391387
[TBL] [Abstract][Full Text] [Related]
10. Nuclear envelope localization of Ran-binding protein 2 and Ran-GTPase-activating protein 1 in psoriatic epidermal keratinocytes.
Yasuda K; Sugiura K; Takeichi T; Ogawa Y; Muro Y; Akiyama M
Exp Dermatol; 2014 Feb; 23(2):119-24. PubMed ID: 24438026
[TBL] [Abstract][Full Text] [Related]
11. High-mobility group box 1 links sensing of reactive oxygen species by huntingtin to its nuclear entry.
Son S; Bowie LE; Maiuri T; Hung CLK; Desmond CR; Xia J; Truant R
J Biol Chem; 2019 Feb; 294(6):1915-1923. PubMed ID: 30538129
[TBL] [Abstract][Full Text] [Related]
12. Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease.
Miki Y; Tanji K; Mori F; Wakabayashi K
Neurobiol Dis; 2015 Feb; 74():25-31. PubMed ID: 25449906
[TBL] [Abstract][Full Text] [Related]
13. Virtual breakdown of the nuclear envelope in fission yeast meiosis.
Asakawa H; Kojidani T; Mori C; Osakada H; Sato M; Ding DQ; Hiraoka Y; Haraguchi T
Curr Biol; 2010 Nov; 20(21):1919-25. PubMed ID: 20970342
[TBL] [Abstract][Full Text] [Related]
14. Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.
Sieradzan KA; Mechan AO; Jones L; Wanker EE; Nukina N; Mann DM
Exp Neurol; 1999 Mar; 156(1):92-9. PubMed ID: 10192780
[TBL] [Abstract][Full Text] [Related]
15. Nucleocytoplasmic transport and nuclear envelope integrity in the fission yeast Schizosaccharomyces pombe.
Yoshida M; Sazer S
Methods; 2004 Jul; 33(3):226-38. PubMed ID: 15157890
[TBL] [Abstract][Full Text] [Related]
16. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell models of Huntington's disease.
Liu KY; Shyu YC; Barbaro BA; Lin YT; Chern Y; Thompson LM; James Shen CK; Marsh JL
Hum Mol Genet; 2015 Mar; 24(6):1602-16. PubMed ID: 25398943
[TBL] [Abstract][Full Text] [Related]
18. Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin.
Tanaka Y; Igarashi S; Nakamura M; Gafni J; Torcassi C; Schilling G; Crippen D; Wood JD; Sawa A; Jenkins NA; Copeland NG; Borchelt DR; Ross CA; Ellerby LM
Neurobiol Dis; 2006 Feb; 21(2):381-91. PubMed ID: 16150600
[TBL] [Abstract][Full Text] [Related]
19. This bud's for you: mechanisms of cellular nucleocytoplasmic trafficking via nuclear envelope budding.
Fradkin LG; Budnik V
Curr Opin Cell Biol; 2016 Aug; 41():125-31. PubMed ID: 27236823
[TBL] [Abstract][Full Text] [Related]
20. Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation.
Wang J; Gines S; MacDonald ME; Gusella JF
BMC Neurosci; 2005 Jan; 6():1. PubMed ID: 15649316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
